- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
- 2.2. Cervical Cancer Diagnostics Market: Snapshot
- Chapter 3. Cervical Cancer Diagnostics Market – Industry Analysis
- 3.1. Cervical Cancer Diagnostics Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Growing incidence of cervical cancer in middle-aged women
- 3.2.2. Increasing number of awareness programs for cervical cancer screening
- 3.3. Restraints
- 3.3.1. Changes in regulatory guidelines for cervical cancer screening
- 3.4. Opportunities
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Test Type
- 3.6.2. Market attractiveness analysis by Region
- Chapter 4. Cervical Cancer Diagnostics Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Cervical Cancer Diagnostics Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New product launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- Chapter 5. Global Cervical Cancer Diagnostics Market – Test Type Analysis
- 5.1. Global Cervical Cancer Diagnostics Market overview: by Test Type
- 5.1.1. Global Cervical Cancer Diagnostics Market share, by Test Type, 2019 and 2026
- 5.2. Pap Testing (Cytulogy Testing)
- 5.2.1. Global Cervical Cancer Diagnostics Market by Pap Testing (Cytulogy Testing), 2016 – 2026 (USD Million)
- 5.3. HPV Testing
- 5.3.1. Global Cervical Cancer Diagnostics Market by HPV Testing, 2016 – 2026 (USD Million)
- 5.4. Culposcopy
- 5.4.1. Global Cervical Cancer Diagnostics Market by Culposcopy, 2016 – 2026 (USD Million)
- 5.5. Cervical Biopsies
- 5.5.1. Global Cervical Cancer Diagnostics Market by Cervical Biopsies, 2016 – 2026 (USD Million)
- 5.6. Cystoscopy
- 5.6.1. Global Cervical Cancer Diagnostics Market by Cystoscopy, 2016 – 2026 (USD Million)
- Chapter 6. Global Cervical Cancer Diagnostics Market - Regional Analysis
- 6.1. Global Cervical Cancer Diagnostics Market overview: by Region
- 6.1.1. Global Cervical Cancer Diagnostics Market share, by Region, 2019 and 2026
- 6.2. North America
- 6.2.1. North America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
- 6.2.2. North America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
- 6.2.3. North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.2.4. U.S.
- 6.2.4.1. U.S. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.2.5. Rest of North America
- 6.2.5.1. Rest of North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
- 6.3.2. Europe Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
- 6.3.3. Europe Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.3.4. U.K.
- 6.3.4.1. U.K. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.3.5. France
- 6.3.5.1. France Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.3.6. Germany
- 6.3.6.1. Germany Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.3.7. Rest of Europe
- 6.3.7.1. Rest of Europe Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
- 6.4.2. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
- 6.4.3. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.4.4. China
- 6.4.4.1. China Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.4.5. Japan
- 6.4.5.1. Japan Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.4.6. India
- 6.4.6.1. India Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.4.7. Rest of Asia Pacific
- 6.4.7.1. Rest of Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
- 6.5.2. Latin America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
- 6.5.3. Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.5.4. Brazil
- 6.5.4.1. Brazil Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.5.5. Rest of Latin America
- 6.5.5.1. Rest of Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.6. The Middle East and Africa
- 6.6.1. The Middle East and Africa Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
- 6.6.2. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
- 6.6.3. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.6.4. GCC Countries
- 6.6.4.1. GCC Countries Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- 6.6.5. Rest of Middle East & Africa
- 6.6.5.1. Rest of Middle East & Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
- Chapter 7. Company Profiles
- 7.1. Abbott Laboratories
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Product Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Qiagen N.V.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Hulogic Inc.
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Roche Diagnostics
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Quest Diagnostics
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. Becton, Dickinson and Company
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Cervical Cancer Diagnostics Market attractiveness, by Test Type
6. Global Cervical Cancer Diagnostics Market attractiveness, by Region
7. Global Cervical Cancer Diagnostics Market share, by Test Type, 2019 and 2026
8. Global Cervical Cancer Diagnostics Market by Pap Testing (Cytology Testing), 2016 – 2026 (USD Million)
9. Global Cervical Cancer Diagnostics Market by HPV Testing, 2016 – 2026 (USD Million)
10. Global Cervical Cancer Diagnostics Market by Colposcopy, 2016 – 2026 (USD Million)
11. Global Cervical Cancer Diagnostics Market by Cervical Biopsies, 2016 – 2026 (USD Million)
12. Global Cervical Cancer Diagnostics Market by Cystoscopy, 2016 – 2026 (USD Million)
13. Global Cervical Cancer Diagnostics Market share, by Region, 2019 and 2026
14. North America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
15. Europe Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
16. Asia Pacific Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
17. Latin America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
18. The Middle East and Africa Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
Table Of Tables
List of Tables
1. Global Cervical Cancer Diagnostics Market: snapshot
2. Drivers of the Cervical Cancer Diagnostics Market: impact analysis
3. Restraints of the Cervical Cancer Diagnostics Market: impact analysis
4. North America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
5. North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
6. U.S. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
7. Rest of North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
8. Europe Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
9. Europe Cervical Cancer Diagnostics Market revenue, by End User, 2016 – 2026 (USD Million)
10. U.K. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
11. France Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
12. Germany Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
13. Rest of Europe Cervical Cancer Diagnostics revenue, by Test Type, 2016 – 2026 (USD Million)
14. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
15. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
16. China Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
17. Japan Cervical Cancer Diagnostics revenue, by Test Type, 2016 – 2026 (USD Million)
18. India Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
19. Rest of Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
20. Latin America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
21. Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
22. Brazil Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
23. Rest of Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
24. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
25. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
26. GCC Countries Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
27. Rest of Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)